Myeloperoxidase Antineutrophil Cytoplasmic Antibodies (MPO-ANCA) in Idiopathic Pulmonary Fibrosis: Prevalence and Risk of Progression to Microscopic Polyangiitis in a UK Cohort - Amsterdam 2025

Technology and imaging in interstitial lung disease/Clinical aspects in interstitial lung disease

Chair(s): Punchalee Kaenmuang, Diana Calaras

Session type: Poster session

Myeloperoxidase Antineutrophil Cytoplasmic Antibodies (MPO-ANCA) in Idiopathic Pulmonary Fibrosis: Prevalence and Risk of Progression to Microscopic Polyangiitis in a UK Cohort

Jonathon Shaw

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Indicators of disease severity and prognosis in patients with IPAF

Ewa Miadlikowska

Poster

Abstract

CT Lung Volume measurements are Useful in Predicting Treatment Response in Idiopathic Pulmonary Fibrosis

Yoshiaki Zaizen

Poster

Abstract

Late Breaking Abstract - Safety, tolerability, and pharmacokinetics of inhaled TGF-?1 modulator in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial

Lixiu He

Poster

Abstract

Deep learning analysis of pulmonary vessel volume (PVV): prognostic implications in idiopathic pulmonary fibrosis (IPF)

Gaetano Rea

Poster

Abstract

Myeloperoxidase Antineutrophil Cytoplasmic Antibodies (MPO-ANCA) in Idiopathic Pulmonary Fibrosis: Prevalence and Risk of Progression to Microscopic Polyangiitis in a UK Cohort

Jonathon Shaw

Poster

Abstract

Short-Term Longitudinal Assessment of Automated Lung Parenchyma Analysis in IPF

Martyna Martka

Poster

Abstract

Functional Characteristics of fibrosing interstitial lung diseases on phase?resolved functional lung magnetic resonance imaging

Yifei Ni

Poster

Abstract

Vertebral fractures as a predictor of reduced forced vital capacity in subject with interstitial lung disease

Loredana Carobene

Poster

Abstract

The need for genetic consultation in lung transplantation for interstitial lung diseases

Martina Sterclová

Poster

Abstract

Motion Diagnosis for Tracheal Change in Interstitial Lung Disease using Respiratory Dynamic CT

Hiroaki Nakagawa

Poster

Abstract

Interstitial Lung Disease (ILD) Associated With Pulmonary Hypertension (PH): Considerations After 2024 World Symposium for Pulmonary Hypertension (WSPH) Guidance A Single ILD Centre Perspective

Jonathon Shaw

Poster

Abstract

Role of 3-D Echo in Predicting Pulmonary Vascular Damage in IPF: a prospective study

Umberto Zanini

Poster

Abstract

The initial CT can predict progressive pulmonary fibrosis in unclassifiable idiopathic interstitial pneumonias

Ryoko Egashira

Poster

Abstract

Deep learning analysis of serial CT scans correlates with changes in how patients feel, function and survive in fibrotic interstitial lung disease

Giles Dixon

Poster

Abstract

Developing and Validation of a Multimodal-based Machine Learning Model for Diagnosis of Usual Interstitial Pneumonia: a Prospective Multicenter Study

Hongyi Wang

Poster

Abstract

SPAIDNet: a Deep Learning-Based Imaging Classification Framework for Interstitial Lung Disease Developed and Validated in A Multicenter Prospective Cohort Study

Hongyi Wang

Poster

Abstract

A CT imaging measure of combined pulmonary fibrosis and emphysema (CPFE)

Jennifer Wang

Poster

Abstract

SPECT-CT imaging of avb3 integrin reveals increased activity in patients with fibrotic interstitial lung disease compared to healthy controls

Giles Dixon

Poster

Abstract

Late Breaking Abstract - Safety and tolerability of nerandomilast in patients with pulmonary fibrosis: pooled data from the FIBRONEER-IPF and FIBRONEER-ILD trials

Justin M Oldham

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}